Medtronic maintains leadership in EVAR market with CE mark of next-gen Endurant stent
This article was originally published in Clinica
Executive Summary
Medtronic has CE marked its next-generation Endurant II stent graft for sale in Europe, a move that could help it maintain its leading position in the endovascular aortic repair (EVAR) market.